NCT06996431

Brief Summary

The objective of this clinical trial is to evaluate whether an innovative care model integrating mobile health (mHealth) support improves weight management in adults with overweight or obesity. The primary research questions are: (1) Does the intervention promote weight change at the 6-month follow-up? (2) Does the intervention enhance physical activity and encourage a healthy diet at the 3- and 6-month follow-ups? To address these questions, researchers will compare the intervention group with a control group to measure changes in weight, physical activity, and dietary habits. At baseline, all participants will complete a survey assessing demographics, body weight, height, central obesity, lifestyle, weight loss history, and expectations. The intervention group will receive a weight management program based on Ecological Momentary Assessment (EMA), incorporating risk-stratified health services, with follow- ups at 3 and 6 months. The control group will receive minimal intervention in the form of general health advice, with follow-ups at the same intervals.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
876

participants targeted

Target at P75+ for not_applicable

Timeline
12mo left

Started Feb 2025

Typical duration for not_applicable

Geographic Reach
1 country

3 active sites

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress56%
Feb 2025Apr 2027

Study Start

First participant enrolled

February 10, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

April 17, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

May 30, 2025

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 16, 2026

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2027

Last Updated

June 11, 2025

Status Verified

June 1, 2025

Enrollment Period

1.8 years

First QC Date

April 17, 2025

Last Update Submit

June 5, 2025

Conditions

Keywords

ecological momentary assessmentweight managementmHealthprimary carestepped-wedgecluster RCTrisk stratificationnurse-led

Outcome Measures

Primary Outcomes (1)

  • Change in weight

    Defined as the change in weight of participants over a specified period, this measurement compares the weight change between the intervention and control groups. Participants' weights will be recorded in kilograms at baseline and at a 6-month follow-up using a calibrated digital scale.

    6-month from baseline

Secondary Outcomes (17)

  • Change in weight

    3- and 12-month from baseline

  • Proportion of overweight or obesity

    3-, 6- and 12-month follow-up from baseline

  • Proportion of participants with ≥5% weight change

    3-, 6- and 12-month follow-up from baseline

  • Change in body fat

    3- and 6-month follow-up from baseline

  • Change in muscle mass

    3- and 6-month follow-up from baseline

  • +12 more secondary outcomes

Study Arms (2)

Control group intervention

ACTIVE COMPARATOR

Participants in the control group will receive minimal Intervention. They will not be provided with risk-stratified services.

Behavioral: Minimal Intervention

EMA-based weight management intervention

EXPERIMENTAL

Participants in the intervention group will join an mobile health (mHealth) weight management program integrating ecological momentary assessment (EMA) via a mobile app, post-EMA counseling, and risk-stratified coaching. This program provides real-time monitoring and personalized feedback to improve diet and physical activity.

Behavioral: EMA-based weight management intervention

Interventions

Participants will complete four 7-day EMA sessions, reporting their diet for 3 days and physical activity for 4 days by completing five brief daily mobile app surveys (under 2 minutes each), using a 5-digit case number for privacy. The app automatically retrieves Fitbit data-such as step count, moderate-to-vigorous physical activity (MVPA), sedentary behavior, and heart rate- and sends timely reminders if surveys are missed. Within one week after the first EMA session, participants will attend a nurse- led counseling session using the 5A Model (Assess, Advise, Agree, Assist, Arrange), providing tailored feedback based on EMA and Fitbit data, and addressing barriers to change. This is followed by risk-based coaching from a dietitian and fitness instructor, with individualized diet and exercise plans. Between sessions, participants receive ongoing support, including instant reminder messaging and weekly motivational messages to encourage healthy behaviors.

EMA-based weight management intervention

Participants will not receive risk-stratified services but will be provided with informational leaflets offering general advice on maintaining a healthy diet, regular exercise, smoking cessation, and alcohol cessation.

Control group intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Hong Kong residents aged ≥18 years;
  • able to read and communicate in Chinese;
  • own a smartphone with internet access;
  • have good mobility alone without gait aid;
  • body mass index ≥ 23.0;
  • and no contraindication for physical activity as evidenced by: If aged \< 70: do not meet any criteria in PAR-Q, or sign declaration of having medical clearance if meet any criteria in PAR-Q; If aged ≥ 70: sign the declaration about conducting physical activity frequently or having medical clearance

You may not qualify if:

  • Have a terminal illness (e.g., advanced cancer, dementia, pulmonary, neurological, motor-neuron, and advanced cardiovascular disease) or with a life expectancy of less than 6 months;
  • currently receiving treatment for any cancer (active cancer patients) or cancer survivor of any GI cancers (e.g. colorectal cancer, stomach cancer);
  • lactating, pregnant or planning for pregnancy in the coming 6 months;
  • have current diagnosis of psychiatric disorder;
  • have previous diagnosis of eating disorder;
  • have diagnoses of gastrointestinal conditions (e.g. Irritable Bowel Syndrome, Ulcerative Colitis, Crohn's Disease, Coeliac Disease);
  • currently receiving intensive diet or exercise treatment;
  • have clinical obesity (e.g. confirmation of excess body fat plus limitations of day-to-day activities or signs or symptoms of obesity-related organ dysfunction). Examples of obesity-related organ dysfunction include NAFLD with hepatic fibrosis, the cluster of hyperglycaemia, high triglyceride levels, and low HDL cholesterol levels. Examples of limitations of day-to-day activities include significant age-adjusted limitations of mobility and/or other basic ADL (e.g. bathing, dressing, toileting, continence, eating).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Aberdeen Kaifong Welfare Association

Hong Kong, Hong Kong

Location

Haven of Hope Christian Service

Hong Kong, Hong Kong

Location

Hong Kong Sheng Kung Hui Welfare Council

Hong Kong, Hong Kong

Location

MeSH Terms

Conditions

OverweightObesityMotor ActivityBody Weight Changes

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsBehavior

Study Officials

  • Siu Chee Chan Professor

    he University of Hong Kong

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
CROSSOVER
Model Details: A stepped-wedge cluster randomized controlled trial will be conducted. This design is considered a type of unidirectional crossover randomized controlled trial (RCT). Stepped-wedge trials evaluate the effect of an intervention implemented at the cluster level. In this design, all clusters initially begin in the control condition. Clusters are then randomized into different sequences, which determine the time point at which each cluster transitions from the control condition to the intervention condition. Once a cluster transitions to the intervention, it remains in that condition for the rest of the study. By the final phase, all clusters, including new participants, will be receiving the intervention.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 17, 2025

First Posted

May 30, 2025

Study Start

February 10, 2025

Primary Completion (Estimated)

December 16, 2026

Study Completion (Estimated)

April 30, 2027

Last Updated

June 11, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will share

The de-identified individual participant data collected during the trial will be shared at 2 years after article publication with no end date.

Shared Documents
STUDY PROTOCOL, ICF

Locations